Cargando…

COVID 19 and Hemoglobinopathies: Update of the Italian Experience

Background. Patients with pre-existent chronic morbidities are likely to be more severely affected by SARS-Cov2 infection. In Italy, the “Società Italiana Talassemie ed Emoglobinopatie” (SITE) has recently estimated the number of patients (Pts) with Hemoglobinopathies followed by Italian Specialized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motta, Irene, Pinto, Valeria Maria, Longo, Filomena, Bonetti, Federico, De Michele, Elisa, Piperno, Alberto, Pitrolo, Lorella, Quaresima, Micol, Ribersani, Michela, Migone De Amicis, Margherita, Balocco, Manuela, Gianesin, Barbara, Graziadei, Giovanna, Cappellini, Maria Domenica, De Franceschi, Lucia, Piga, Antonio, Forni, Gian Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	112.Thalassemia and Globin Gene Regulation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330197/ http://dx.doi.org/10.1182/blood-2020-141610

Ejemplares similares

Adverse Events Following COVID-19 Vaccination in Transfusion-Dependent -Thalassemia Patients
por: Delaporta, Polyxeni, et al.
Publicado: (2021)

Serological Response to BNT162b2 Anti-Sars-Cov-2 mRNA Vaccine in Patients with Transfusion Dependent Thalassemia
por: Zucano, Stefania, et al.
Publicado: (2021)

Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting
por: Pinto, Valeria Maria, et al.
Publicado: (2022)

Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department
por: Forni, Gian Luca, et al.
Publicado: (2014)

Influence of different antioxidant agents on the microtensile bond strength of restored teeth after bleaching
por: Lobo, Sofia, et al.
Publicado: (2021)

Risk of sarcopoenia and prevention of disability in post COVID 19 elderly patients
por: D'Amico, Ferdinando, et al.
Publicado: (2021)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
por: Iolascon, Achille, et al.
Publicado: (2019)

Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021
por: Origa, Raffaella, et al.
Publicado: (2022)

Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy
por: Motta, Irene, et al.
Publicado: (2021)

A Suspected Case of Cerebral Fat Embolism Triggering a Drug-resistant Status Epilepticus in a HbS/β(+)-Thalassaemia Patient
por: Bortolotti, Marta, et al.
Publicado: (2022)

Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2022)

Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia
por: Derchi, Giorgio, et al.
Publicado: (2022)

When to start: as soon as possible
por: Saag, M
Publicado: (2012)

Acquired Refractory Iron Deficiency Anemia
por: Migone De Amicis, Margherita, et al.
Publicado: (2021)

Catheter ablation of left atrial tachyarrhythmia: predictors of recurrence after catheter ablation
por: Marazzato, J, et al.
Publicado: (2023)

Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

Management of the Sickle Cell Trait: An Opinion by Expert Panel Members
por: Pinto, Valeria Maria, et al.
Publicado: (2023)

Updates in Hemoglobinopathies
por: Al-Tonbary, Youssef, et al.
Publicado: (2013)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
por: Ehret, Robert, et al.
Publicado: (2014)

Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020)

Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020)

Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS)
por: Lam, Ho Pui Jeff, et al.
Publicado: (2020)

Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection
por: Merz, Lauren E., et al.
Publicado: (2020)

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic
por: Davila, Jennifer G., et al.
Publicado: (2020)

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020)

Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
por: Abdelaal, Mahmoud A.Z., et al.
Publicado: (2020)

Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina
por: Noisette, Laurence, et al.
Publicado: (2020)

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome
por: Tanenbaum, Mira T, et al.
Publicado: (2019)

Syncope in patients with diagnosed with hypertrophic cardiomyopathy: risk of ventricular tachycardia, cardiac arrest and death
por: Zoerner, C R, et al.
Publicado: (2023)

P1461: INFLAMMATORY AND SENESCENCE-ASSOCIATED MEDIATORS AFFECT THE PERSISTENCE OF HUMORAL RESPONSE TO COVID-19 MRNA VACCINATION IN TRANSFUSION-DEPENDENT BETA-THALASSEMIC PATIENTS
por: Bordoni, Veronica, et al.
Publicado: (2023)

Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

Hemoglobinopathy and pediatrics in the time of COVID-19
por: Vilela, Thiago de Souza, et al.
Publicado: (2021)

Current challenges in the management of patients with sickle cell disease – A report of the Italian experience
por: Russo, Giovanna, et al.
Publicado: (2019)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)

Hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rare Combinational Hemoglobinopathies
por: Husan, Ammar, et al.
Publicado: (2022)

Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches
por: Motta, Irene, et al.
Publicado: (2019)

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
por: Carsetti, Rita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o9m8q31df5ruqvgkve97slg946